Skip to main content
. 2017 Feb 1;8(10):16531–16552. doi: 10.18632/oncotarget.14972

Figure 12. AEG-1-shRNA inhibited the tumorigenic and angiogenic ability of the H460 cells.

Figure 12

(A) Tumor xenografts was formed in chorioallantoic membranes (CAMs) in MOCK group. After removing the xenografts, the size was measured. (B) Tumor xenografts was formed in chorioallantoic membranes (CAMs) in NC group. After removing the xenografts, the size was measured. (C) The tumorigenic ability of the mock, NC and AEG-1-shRNA groups. The graph represents the Mean ±SD. (****P < 0.0001) (D) Hematoxylin/eosin (HE) staining of the tumor xenografts (× 400).